In-vitro modeling of TKI resistance in the high-risk B-cell acute lymphoblastic leukemia fusion gene RANBP2-ABL1 - implications for targeted therapy
暂无分享,去创建一个
S. Heatley | D. White | T. Hughes | D. Yeung | L. Eadie | B. McClure | T. Leclercq | Kartini Asari | Caitlin E Schutz | T. Hughes | D. White